Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex ...

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Vertex Pharmaceuticals sees early success with Journavx painkiller, potential revenue growth from drug and gene therapy.

As we gathered data, surveyed people and set up experiments, it became clear that those tiny shortcuts -- sometimes hailed as ...

Morgan Stanley raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $462 from $459 and keeps an Equal Weight rating on the ...

Vertex AI is Google's platform for developers to build, train and test generative-AI apps. As of this week, it has some new music features.

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ SCHEDULE 14 A Proxy Statement Pursuant to Section 14 of the Securities Exchange Act of ...

Here's how to fold your own envelope. Just use leftover scrapbook paper or any decorative paper you have at home.

Efficient text entry without an actual keyboard remains an industry-wide challenge for unlocking productivity use-cases in XR headsets. Researchers have created a comprehensive catalog of existing ...

Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...

In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...

People have a tendency to tell stories chronologically. Newswriting style is not chronological. The inverted pyramid turns storytelling on its head. Picture an upside-down triangle: the broad base ...